Skip to content
The Nexus
DossierENTITY

Dr. Philip Rabito

Coverage of Dr. Philip Rabito in the Nexus archive.

Earliest in view: May 1 · 11:00 UTCMost recent: May 1 · 11:00 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHMay 1 · 11:00 UTCFOX NEWS
    Thinking about peptides? Doctors reveal key dos and don’ts as ‘Wild West’ market grows

    The peptide market is expanding rapidly, driven by popularity among wellness influencers and claims of benefits like muscle growth and anti-aging. However, many peptides lack FDA safety and efficacy oversight, raising concerns as the FDA considers easing restrictions. Experts warn of risks from unregulated products and emphasize the need for clinical rationale and professional guidance.

Dr. Philip Rabito · Dossier · The Nexus